Open access
Aug 2026
Absence of Interference on in vitro Clinical Diagnostic Assays Often Performed on Hospitalized Patients by Relmapirazin, a Fluorescent Tracer Agent for Point-of-Care Assessment of Glomerular Filtration Rate.
Investigation of possible interference this agent may induce with typical clinical diagnostic assays given to incoming and hospitalized patients found no interference from relmapirazin was detected in the suite of metabolic and cardiac assays evaluated.
R. Dorshow, N. Morrison, Margot Borgel
· International journal of tox... · 0 citations